British Bio Seeking Partners For Three Projects After Zacutex Termination
Executive Summary
British Biotech will focus its discovery research on metallo-enzyme inhibition programs and seek partnerships for several compounds following the discontinuation of the pancreatitis therapy Zacutex (lexipafant), the firm announced March 25.